CD1-restricted T cell response in atherosclerosis

动脉粥样硬化中 CD1 限制性 T 细胞反应

基本信息

项目摘要

DESCRIPTION (provided by applicant): The cluster of differentiation I (CD1) proteins represent a new class of antigen-presenting molecules, which structurally resemble MHC class I antigens and may restrict certain T lymphocyte responses to lipid antigens. There are two groups of CD1 molecules encoded by five CD1 genes (CD1a, b, c, d and e). Atherosclerotic lesions contain numerous T cells and CD1-positive macrophages and dendritic cells in addition to chemically modified lipids (e.g., cholesterol oxides or oxysterols and oxidized phospholipids) present in oxidized lipoproteins, raising the possibility that CD1-restricted T cells may exist in the lesions and respond to atherogenic lipid antigens presented by local macrophages and dendritic cells. The specific aims of this proposal are to determine (1) the CD1 isotype expression and CD1-restricted T cell response to lipid components of oxidized lipoproteins in atherosclerosis; (2) the association of an CD1 mutation or polymorphism with altered vascular autoimmunity in patients with SLE and atherosclerosis; (3) the cytokine production and pro-apoptotic function of CD1d-restricted NK T cells that are reactive to lipid antigens; and (4) the impact of knocking out CD1d gene on the T cell responses to lipid antigens and the development of atherosclerosis caused by apolipoprotein-E deficiency. The experimental procedures involve the analysis of T cell cytokine production and antigen receptor profiles, the evaluation of T cell response to CD1- lipid complexes, the assessment of genomic DNA sequences for CD1 genes, and the histopathological characterization of atherosclerotic lesions in the CD1/apolipoprotein-E double knockout mice recently established in our lab. Accomplishment of this project is anticipated to generate valuable information that help understand the immune mechanisms underlying vascular injury during atherogenesis.
描述(由申请人提供):

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MicroRNA-221 regulates high glucose-induced endothelial dysfunction.
Inhibition of Gata4 and Tbx5 by Nicotine-Mediated DNA Methylation in Myocardial Differentiation.
尼古丁介导的 DNA 甲基化对心肌分化中 Gata4 和 Tbx5 的抑制
  • DOI:
    10.1016/j.stemcr.2016.12.016
  • 发表时间:
    2017-02-14
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Jiang XY;Feng YL;Ye LT;Li XH;Feng J;Zhang MZ;Shelat HS;Wassler M;Li Y;Geng YJ;Yu XY
  • 通讯作者:
    Yu XY
Characterization of a novel ubiquitin-conjugating enzyme that regulates beta1,4-galactosyltransferase-1 in embryonic stem cells.
一种调节胚胎干细胞中 β1,4-半乳糖基转移酶-1 的新型泛素结合酶的表征。
  • DOI:
    10.1634/stemcells.2007-1080
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wassler,MichaelJ;Shur,BarryD;Zhou,Wenxia;Geng,Yong-Jian
  • 通讯作者:
    Geng,Yong-Jian
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yong-Jian Geng其他文献

Yong-Jian Geng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yong-Jian Geng', 18)}}的其他基金

The Pathology/Histology Core
病理学/组织学核心
  • 批准号:
    7140876
  • 财政年份:
    2006
  • 资助金额:
    $ 43.93万
  • 项目类别:
CD1-RESTRICTED T CELL RESPONSE IN ATHEROSCLEROSIS
动脉粥样硬化中 CD1 限制的 T 细胞反应
  • 批准号:
    6744661
  • 财政年份:
    2001
  • 资助金额:
    $ 43.93万
  • 项目类别:
CD1-restricted T cell response in atherosclerosis
动脉粥样硬化中 CD1 限制性 T 细胞反应
  • 批准号:
    6618061
  • 财政年份:
    2001
  • 资助金额:
    $ 43.93万
  • 项目类别:
CD1-restricted T cell response in atherosclerosis
动脉粥样硬化中 CD1 限制性 T 细胞反应
  • 批准号:
    6661075
  • 财政年份:
    2001
  • 资助金额:
    $ 43.93万
  • 项目类别:
CD1-restricted T cell response in atherosclerosis
动脉粥样硬化中 CD1 限制性 T 细胞反应
  • 批准号:
    6528180
  • 财政年份:
    2001
  • 资助金额:
    $ 43.93万
  • 项目类别:
CD1-restricted T cell response in atherosclerosis
动脉粥样硬化中 CD1 限制性 T 细胞反应
  • 批准号:
    6442758
  • 财政年份:
    2001
  • 资助金额:
    $ 43.93万
  • 项目类别:
APOPTOTIC CASCADE IN ATHEROSCLEROSIS
动脉粥样硬化中的细胞凋亡级联
  • 批准号:
    6184280
  • 财政年份:
    1998
  • 资助金额:
    $ 43.93万
  • 项目类别:
APOPTOTIC CASCADE IN ATHEROSCLEROSIS
动脉粥样硬化中的细胞凋亡级联
  • 批准号:
    6323496
  • 财政年份:
    1998
  • 资助金额:
    $ 43.93万
  • 项目类别:
APOPTOTIC CASCADE IN ATHEROSCLEROSIS
动脉粥样硬化中的细胞凋亡级联
  • 批准号:
    2446568
  • 财政年份:
    1998
  • 资助金额:
    $ 43.93万
  • 项目类别:
APOPTOTIC CASCADE IN ATHEROSCLEROSIS
动脉粥样硬化中的细胞凋亡级联
  • 批准号:
    6389778
  • 财政年份:
    1998
  • 资助金额:
    $ 43.93万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.93万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 43.93万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了